The ability to make patient-specific products quickly fits with the needs of smaller, resource-limited developers.

Barcelona’s blood and tissue bank says it has developed a new system for the large-scale production of mesenchymal stromal ...

For some trees, wasted bark is a potential treasure-trove of biopharmaceuticals—from anti-inflammatories to cancer-fighting ...

FDA Commissioner Martin Makary, MD, shared his vision for a “New FDA” with biopharma leaders attending BIO in Boston.

FDA Commissioner Martin Makary, MD, shared his vision for a “New FDA”—one that would decide on drug applications much faster, ...

Noetik will use its multimodal AI models to identify which patients will most likely benefit from Agenus’s lead ...

MICB and NOTCH4 were expressed in fibroblasts and endothelial cells, two cell types that play central roles in fibrosis and vasculopathy.

Researchers say using physically patterned surfaces applied to existing device materials would reduce barriers to commercial application.

RNA-seq and spatial transcriptomics showed immune cell subsets that drive kidney and lung complications in systemic sclerosis patients.

An independent jury of experts will evaluate entries based on scientific merit, feasibility, and potential patient impact.

Advances are occurring in spectroscopy, reducing the challenges of rapid signal saturation and the need for extensive sample prep.